Rapid A1c Test Aims to Reduce Diabetes Diagnosis Inaccuracies
Orange Biomed is currently conducting studies of a rapid A1c, a glycated hemoglobin analyzer through single-cell analysis of red blood cells.
Read MorePosted by Chris Wolski | Apr 19, 2023 | Diabetes & Metabolic Diseases, POC Instruments |
Orange Biomed is currently conducting studies of a rapid A1c, a glycated hemoglobin analyzer through single-cell analysis of red blood cells.
Read MorePosted by Andy Lundin | Dec 6, 2022 | Dementias & Alzheimer’s, Diabetes & Metabolic Diseases |
A scientist is developing health information tech designed to enhance accessibility and value to adults with diabetes and Alzheimer’s disease.
Read MorePosted by Andy Lundin | Nov 24, 2022 | Diabetes & Metabolic Diseases |
Using a standard diabetes test to screen all adults in U.K. aged 40-70 years would find undiagnosed cases of type 2 diabetes much earlier.
Read MorePosted by Andy Lundin | Nov 15, 2022 | Diabetes & Metabolic Diseases, Kidney Disease |
A personalized approach to kidney disease screening for type 1 diabetes patients may reduce the time chronic kidney disease goes undetected.
Read MorePosted by Chris Wolski | Nov 11, 2022 | Diabetes & Metabolic Diseases |
A proteomics approach was used to identify a three-protein signature in the blood that can improve detection of a form of prediabetes.
Read More